APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lesinurad

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Lesinurad Market Analysis and Forecast 2026-2032

1 February 2026217 pages

Choose your research edition.

Industry ResearchLesinurad Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Lesinurad Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Lesinurad Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lesinurad Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Lesinurad Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Lesinurad market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Lesinurad's global sales reached XX (t) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned Ausun Pharmaceutical as the global sales leader, a title it has maintained for several consecutive years. Notably, Ausun Pharmaceutical's performance in primary markets is also remarkable. In the Chinese market, sales were XX (t), a change of XX% from the previous year. In Europe, sales were XX (t), showing a year-on-year of XX%. In the US, sales were XX (t), a year-on-year change of XX%.

The major global manufacturers in the Lesinurad market include Ausun Pharmaceutical, Cayman Chemical, CHEMO, Clearsynth, Manus Aktteva Biopharma LLP, MSN Labs, Nifty Labs, Target Mol and UQUIFA, etc. In 2025, the top three vendors accounted for approximately % of the revenue.

Read the full market overview

In terms of production side, this report researches the Lesinurad production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of Lesinurad by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for Lesinurad, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Lesinurad, also provides the consumption of main regions and countries. Of the upcoming market potential for Lesinurad, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lesinurad sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Lesinurad market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Lesinurad sales, projected growth trends, production technology, application and end-user industry.

Lesinurad Segment by Company

Ausun Pharmaceutical

Cayman Chemical

CHEMO

Clearsynth

Manus Aktteva Biopharma LLP

MSN Labs

Nifty Labs

Target Mol

UQUIFA

Meso Chem

Vcare Pharmatech

Lesinurad Segment by Type

Purity ≥ 98 %

Purity ≥ 99 %

Lesinurad Segment by Application

Research Institute

Pharmaceutical

Others

Lesinurad Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lesinurad market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lesinurad and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lesinurad.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Lesinurad production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Lesinurad in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Lesinurad manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lesinurad sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lesinurad Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Purity ≥ 98 % Major Manufacturers Table 3. Purity ≥ 99 % Major Manufacturers Table 4. Global Lesinurad Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Research Institute Major Manufacturers Table 6. Pharmaceutical Major Manufacturers Table 7. Others Major Manufacturers Table 8. Lesinurad Industry Trends Table 9. Lesinurad Industry Drivers Table 10. Lesinurad Industry Opportunities and Challenges Table 11. Lesinurad Industry Restraints Table 12. Global Lesinurad Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (t) Table 13. Global Lesinurad Production by Region (2021-2026) & (t) Table 14. Global Lesinurad Production by Region (2027-2032) & (t) Table 15. Global Lesinurad Production Market Share by Region (2021-2026) Table 16. Global Lesinurad Production Market Share by Region (2027-2032) Table 17. Global Lesinurad Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Lesinurad Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Lesinurad Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Lesinurad Revenue Market Share by Region (2021-2026) Table 21. Global Lesinurad Revenue Market Share by Region (2027-2032) Table 22. Global Lesinurad Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (t) Table 23. Global Lesinurad Sales by Region (2021-2026) & (t) Table 24. Global Lesinurad Sales by Region (2027-2032) & (t) Table 25. Global Lesinurad Sales Market Share by Region (2021-2026) Table 26. Global Lesinurad Sales Market Share by Region (2027-2032) Table 27. Global Lesinurad Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Lesinurad Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Lesinurad Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Lesinurad Sales Market Share by Manufacturers (2021-2026) Table 31. Global Lesinurad Sales Price (USD/t) of Manufacturers (2021-2026) Table 32. Global Lesinurad Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Lesinurad Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Lesinurad Manufacturers, Product Type & Application Table 35. Global Lesinurad Manufacturers Commercialization Time Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Lesinurad by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 38. Global Lesinurad Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Lesinurad Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Lesinurad Revenue Market Share by Type (2021-2026) Table 41. Global Lesinurad Revenue Market Share by Type (2027-2032) Table 42. Global Lesinurad Sales by Type (2021-2026) & (t) Table 43. Global Lesinurad Sales by Type (2027-2032) & (t) Table 44. Global Lesinurad Sales Market Share by Type (2021-2026) Table 45. Global Lesinurad Sales Market Share by Type (2027-2032) Table 46. Global Lesinurad Price by Type (2021-2026) & (USD/t) Table 47. Global Lesinurad Price by Type (2027-2032) & (USD/t) Table 48. Global Lesinurad Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Lesinurad Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Lesinurad Revenue Market Share by Application (2021-2026) Table 51. Global Lesinurad Revenue Market Share by Application (2027-2032) Table 52. Global Lesinurad Sales by Application (2021-2026) & (t) Table 53. Global Lesinurad Sales by Application (2027-2032) & (t) Table 54. Global Lesinurad Sales Market Share by Application (2021-2026) Table 55. Global Lesinurad Sales Market Share by Application (2027-2032) Table 56. Global Lesinurad Price by Application (2021-2026) & (USD/t) Table 57. Global Lesinurad Price by Application (2027-2032) & (USD/t) Table 58. Ausun Pharmaceutical Company Information Table 59. Ausun Pharmaceutical Business Overview Table 60. Ausun Pharmaceutical Lesinurad Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 61. Ausun Pharmaceutical Lesinurad Product Portfolio Table 62. Ausun Pharmaceutical Recent Development Table 63. Cayman Chemical Company Information Table 64. Cayman Chemical Business Overview Table 65. Cayman Chemical Lesinurad Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 66. Cayman Chemical Lesinurad Product Portfolio Table 67. Cayman Chemical Recent Development Table 68. CHEMO Company Information Table 69. CHEMO Business Overview Table 70. CHEMO Lesinurad Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 71. CHEMO Lesinurad Product Portfolio Table 72. CHEMO Recent Development Table 73. Clearsynth Company Information Table 74. Clearsynth Business Overview Table 75. Clearsynth Lesinurad Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 76. Clearsynth Lesinurad Product Portfolio Table 77. Clearsynth Recent Development Table 78. Manus Aktteva Biopharma LLP Company Information Table 79. Manus Aktteva Biopharma LLP Business Overview Table 80. Manus Aktteva Biopharma LLP Lesinurad Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 81. Manus Aktteva Biopharma LLP Lesinurad Product Portfolio Table 82. Manus Aktteva Biopharma LLP Recent Development Table 83. MSN Labs Company Information Table 84. MSN Labs Business Overview Table 85. MSN Labs Lesinurad Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 86. MSN Labs Lesinurad Product Portfolio Table 87. MSN Labs Recent Development Table 88. Nifty Labs Company Information Table 89. Nifty Labs Business Overview Table 90. Nifty Labs Lesinurad Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 91. Nifty Labs Lesinurad Product Portfolio Table 92. Nifty Labs Recent Development Table 93. Target Mol Company Information Table 94. Target Mol Business Overview Table 95. Target Mol Lesinurad Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 96. Target Mol Lesinurad Product Portfolio Table 97. Target Mol Recent Development Table 98. UQUIFA Company Information Table 99. UQUIFA Business Overview Table 100. UQUIFA Lesinurad Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 101. UQUIFA Lesinurad Product Portfolio Table 102. UQUIFA Recent Development Table 103. Meso Chem Company Information Table 104. Meso Chem Business Overview Table 105. Meso Chem Lesinurad Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 106. Meso Chem Lesinurad Product Portfolio Table 107. Meso Chem Recent Development Table 108. Vcare Pharmatech Company Information Table 109. Vcare Pharmatech Business Overview Table 110. Vcare Pharmatech Lesinurad Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 111. Vcare Pharmatech Lesinurad Product Portfolio Table 112. Vcare Pharmatech Recent Development Table 113. North America Lesinurad Revenue by Type (2021-2026) & (US$ Million) Table 114. North America Lesinurad Revenue by Type (2027-2032) & (US$ Million) Table 115. North America Lesinurad Sales by Type (2021-2026) & (t) Table 116. North America Lesinurad Sales by Type (2027-2032) & (t) Table 117. North America Lesinurad Sales Price by Type (2021-2026) & (USD/t) Table 118. North America Lesinurad Sales Price by Type (2027-2032) & (USD/t) Table 119. North America Lesinurad Revenue by Application (2021-2026) & (US$ Million) Table 120. North America Lesinurad Revenue by Application (2027-2032) & (US$ Million) Table 121. North America Lesinurad Sales by Application (2021-2026) & (t) Table 122. North America Lesinurad Sales by Application (2027-2032) & (t) Table 123. North America Lesinurad Sales Price by Application (2021-2026) & (USD/t) Table 124. North America Lesinurad Sales Price by Application (2027-2032) & (USD/t) Table 125. North America Lesinurad Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. North America Lesinurad Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 127. North America Lesinurad Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 128. North America Lesinurad Sales by Country (2021 VS 2025 VS 2032) & (t) Table 129. North America Lesinurad Sales by Country (2021-2026) & (t) Table 130. North America Lesinurad Sales by Country (2027-2032) & (t) Table 131. North America Lesinurad Sales Price by Country (2021-2026) & (USD/t) Table 132. North America Lesinurad Sales Price by Country (2027-2032) & (USD/t) Table 133. United States Lesinurad Revenue (2021-2032) & (US$ Million) Table 134. Canada Lesinurad Revenue (2021-2032) & (US$ Million) Table 135. Mexico Lesinurad Revenue (2021-2032) & (US$ Million) Table 136. Europe Lesinurad Revenue by Type (2021-2026) & (US$ Million) Table 137. Europe Lesinurad Revenue by Type (2027-2032) & (US$ Million) Table 138. Europe Lesinurad Sales by Type (2021-2026) & (t) Table 139. Europe Lesinurad Sales by Type (2027-2032) & (t) Table 140. Europe Lesinurad Sales Price by Type (2021-2026) & (USD/t) Table 141. Europe Lesinurad Sales Price by Type (2027-2032) & (USD/t) Table 142. Europe Lesinurad Revenue by Application (2021-2026) & (US$ Million) Table 143. Europe Lesinurad Revenue by Application (2027-2032) & (US$ Million) Table 144. Europe Lesinurad Sales by Application (2021-2026) & (t) Table 145. Europe Lesinurad Sales by Application (2027-2032) & (t) Table 146. Europe Lesinurad Sales Price by Application (2021-2026) & (USD/t) Table 147. Europe Lesinurad Sales Price by Application (2027-2032) & (USD/t) Table 148. Europe Lesinurad Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Europe Lesinurad Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 150. Europe Lesinurad Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 151. Europe Lesinurad Sales by Country (2021 VS 2025 VS 2032) & (t) Table 152. Europe Lesinurad Sales by Country (2021-2026) & (t) Table 153. Europe Lesinurad Sales by Country (2027-2032) & (t) Table 154. Europe Lesinurad Sales Price by Country (2021-2026) & (USD/t) Table 155. Europe Lesinurad Sales Price by Country (2027-2032) & (USD/t) Table 156. Germany Lesinurad Revenue (2021-2032) & (US$ Million) Table 157. France Lesinurad Revenue (2021-2032) & (US$ Million) Table 158. U.K. Lesinurad Revenue (2021-2032) & (US$ Million) Table 159. Italy Lesinurad Revenue (2021-2032) & (US$ Million) Table 160. Russia Lesinurad Revenue (2021-2032) & (US$ Million) Table 161. Spain Lesinurad Revenue (2021-2032) & (US$ Million) Table 162. Netherlands Lesinurad Revenue (2021-2032) & (US$ Million) Table 163. Switzerland Lesinurad Revenue (2021-2032) & (US$ Million) Table 164. Sweden Lesinurad Revenue (2021-2032) & (US$ Million) Table 165. Poland Lesinurad Revenue (2021-2032) & (US$ Million) Table 166. China Lesinurad Revenue by Type (2021-2026) & (US$ Million) Table 167. China Lesinurad Revenue by Type (2027-2032) & (US$ Million) Table 168. China Lesinurad Sales by Type (2021-2026) & (t) Table 169. China Lesinurad Sales by Type (2027-2032) & (t) Table 170. China Lesinurad Sales Price by Type (2021-2026) & (USD/t) Table 171. China Lesinurad Sales Price by Type (2027-2032) & (USD/t) Table 172. China Lesinurad Revenue by Application (2021-2026) & (US$ Million) Table 173. China Lesinurad Revenue by Application (2027-2032) & (US$ Million) Table 174. China Lesinurad Sales by Application (2021-2026) & (t) Table 175. China Lesinurad Sales by Application (2027-2032) & (t) Table 176. China Lesinurad Sales Price by Application (2021-2026) & (USD/t) Table 177. China Lesinurad Sales Price by Application (2027-2032) & (USD/t) Table 178. Asia Lesinurad Revenue by Type (2021-2026) & (US$ Million) Table 179. Asia Lesinurad Revenue by Type (2027-2032) & (US$ Million) Table 180. Asia Lesinurad Sales by Type (2021-2026) & (t) Table 181. Asia Lesinurad Sales by Type (2027-2032) & (t) Table 182. Asia Lesinurad Sales Price by Type (2021-2026) & (USD/t) Table 183. Asia Lesinurad Sales Price by Type (2027-2032) & (USD/t) Table 184. Asia Lesinurad Revenue by Application (2021-2026) & (US$ Million) Table 185. Asia Lesinurad Revenue by Application (2027-2032) & (US$ Million) Table 186. Asia Lesinurad Sales by Application (2021-2026) & (t) Table 187. Asia Lesinurad Sales by Application (2027-2032) & (t) Table 188. Asia Lesinurad Sales Price by Application (2021-2026) & (USD/t) Table 189. Asia Lesinurad Sales Price by Application (2027-2032) & (USD/t) Table 190. Asia Lesinurad Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. Asia Lesinurad Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 192. Asia Lesinurad Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 193. Asia Lesinurad Sales by Country (2021 VS 2025 VS 2032) & (t) Table 194. Asia Lesinurad Sales by Country (2021-2026) & (t) Table 195. Asia Lesinurad Sales by Country (2027-2032) & (t) Table 196. Asia Lesinurad Sales Price by Country (2021-2026) & (USD/t) Table 197. Asia Lesinurad Sales Price by Country (2027-2032) & (USD/t) Table 198. Japan Lesinurad Revenue (2021-2032) & (US$ Million) Table 199. South Korea Lesinurad Revenue (2021-2032) & (US$ Million) Table 200. India Lesinurad Revenue (2021-2032) & (US$ Million) Table 201. Australia Lesinurad Revenue (2021-2032) & (US$ Million) Table 202. Taiwan Lesinurad Revenue (2021-2032) & (US$ Million) Table 203. Southeast Asia Lesinurad Revenue (2021-2032) & (US$ Million) Table 204. SAMEA Lesinurad Revenue by Type (2021-2026) & (US$ Million) Table 205. SAMEA Lesinurad Revenue by Type (2027-2032) & (US$ Million) Table 206. SAMEA Lesinurad Sales by Type (2021-2026) & (t) Table 207. SAMEA Lesinurad Sales by Type (2027-2032) & (t) Table 208. SAMEA Lesinurad Sales Price by Type (2021-2026) & (USD/t) Table 209. SAMEA Lesinurad Sales Price by Type (2027-2032) & (USD/t) Table 210. SAMEA Lesinurad Revenue by Application (2021-2026) & (US$ Million) Table 211. SAMEA Lesinurad Revenue by Application (2027-2032) & (US$ Million) Table 212. SAMEA Lesinurad Sales by Application (2021-2026) & (t) Table 213. SAMEA Lesinurad Sales by Application (2027-2032) & (t) Table 214. SAMEA Lesinurad Sales Price by Application (2021-2026) & (USD/t) Table 215. SAMEA Lesinurad Sales Price by Application (2027-2032) & (USD/t) Table 216. SAMEA Lesinurad Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 217. SAMEA Lesinurad Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 218. SAMEA Lesinurad Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 219. SAMEA Lesinurad Sales by Country (2021 VS 2025 VS 2032) & (t) Table 220. SAMEA Lesinurad Sales by Country (2021-2026) & (t) Table 221. SAMEA Lesinurad Sales by Country (2027-2032) & (t) Table 222. SAMEA Lesinurad Sales Price by Country (2021-2026) & (USD/t) Table 223. SAMEA Lesinurad Sales Price by Country (2027-2032) & (USD/t) Table 224. Brazil Lesinurad Revenue (2021-2032) & (US$ Million) Table 225. Argentina Lesinurad Revenue (2021-2032) & (US$ Million) Table 226. Chile Lesinurad Revenue (2021-2032) & (US$ Million) Table 227. Colombia Lesinurad Revenue (2021-2032) & (US$ Million) Table 228. Peru Lesinurad Revenue (2021-2032) & (US$ Million) Table 229. Saudi Arabia Lesinurad Revenue (2021-2032) & (US$ Million) Table 230. Israel Lesinurad Revenue (2021-2032) & (US$ Million) Table 231. UAE Lesinurad Revenue (2021-2032) & (US$ Million) Table 232. Turkey Lesinurad Revenue (2021-2032) & (US$ Million) Table 233. Iran Lesinurad Revenue (2021-2032) & (US$ Million) Table 234. Egypt Lesinurad Revenue (2021-2032) & (US$ Million) Table 235. Key Raw Materials Table 236. Raw Materials Key Suppliers Table 237. Lesinurad Distributors List Table 238. Lesinurad Customers List Table 239. Research Programs/Design for This Report Table 240. Authors List of This Report Table 241. Secondary Sources Table 242. Primary Sources List of Figures Figure 1. Lesinurad Product Image Figure 2. Global Lesinurad Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lesinurad Market Size Share 2021 VS 2025 VS 2032 Figure . Purity ≥ 98 % Image Figure 1. Purity ≥ 99 % Image Figure 2. Global Lesinurad Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lesinurad Market Size Share 2021 VS 2025 VS 2032 Figure 4. Research Institute Image Figure 5. Pharmaceutical Image Figure 6. Others Image Figure 7. Global Lesinurad Capacity, Capacity Utilization (2021-2032) & (t) Figure 8. Global Lesinurad Production by Region: 2021 VS 2025 VS 2032 (t) Figure 9. Global Lesinurad Production Market Share by Region: 2025 Versus 2032 Figure 10. Global Lesinurad Production Market Share by Region (2021-2032) Figure 11. North America Lesinurad Production Growth Rate (2021-2032) & (t) Figure 12. Europe Lesinurad Production Growth Rate (2021-2032) & (t) Figure 13. China Lesinurad Production Growth Rate (2021-2032) & (t) Figure 14. Japan Lesinurad Production Growth Rate (2021-2032) & (t) Figure 15. Global Lesinurad Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Lesinurad Revenue (2021-2032) & (US$ Million) Figure 17. Global Lesinurad Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Lesinurad Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Lesinurad Revenue Market Share by Region (2021-2032) Figure 20. Global Lesinurad Sales (2021-2032) & (t) Figure 21. Global Lesinurad Sales by Region: 2021 VS 2025 VS 2032 (t) Figure 22. Global Lesinurad Sales Market Share by Region (2021-2032) Figure 23. North America Lesinurad Sales YoY (2021-2032) & (t) Figure 24. Europe Lesinurad Sales YoY (2021-2032) & (t) Figure 25. China Lesinurad Sales YoY (2021-2032) & (t) Figure 26. Asia (Excluding China) Lesinurad Sales YoY (2021-2032) & (t) Figure 27. South America, Middle East and Africa Lesinurad Sales YoY (2021-2032) & (t) Figure 28. Global Lesinurad Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Lesinurad Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Lesinurad Revenue Market Share by Type (2021-2032) Figure 32. Global Lesinurad Sales Market Share by Type (2021-2032) Figure 33. Global Lesinurad Revenue Market Share by Application (2021-2032) Figure 34. Global Lesinurad Sales Market Share by Application (2021-2032) Figure 35. North America Lesinurad Revenue Share by Type (2021-2032) Figure 36. North America Lesinurad Sales Share by Type (2021-2032) Figure 37. North America Lesinurad Revenue Share by Application (2021-2032) Figure 38. North America Lesinurad Sales Share by Application (2021-2032) Figure 39. North America Lesinurad Revenue Share by Country (2021-2032) Figure 40. North America Lesinurad Sales Share by Country (2021-2032) Figure 41. Europe Lesinurad Revenue Share by Type (2021-2032) Figure 42. Europe Lesinurad Sales Share by Type (2021-2032) Figure 43. Europe Lesinurad Revenue Share by Application (2021-2032) Figure 44. Europe Lesinurad Sales Share by Application (2021-2032) Figure 45. Europe Lesinurad Revenue Share by Country (2021-2032) Figure 46. Europe Lesinurad Sales Share by Country (2021-2032) Figure 47. China Lesinurad Revenue Share by Type (2021-2032) Figure 48. China Lesinurad Sales Share by Type (2021-2032) Figure 49. China Lesinurad Revenue Share by Application (2021-2032) Figure 50. China Lesinurad Sales Share by Application (2021-2032) Figure 51. Asia Lesinurad Revenue Share by Type (2021-2032) Figure 52. Asia Lesinurad Sales Share by Type (2021-2032) Figure 53. Asia Lesinurad Revenue Share by Application (2021-2032) Figure 54. Asia Lesinurad Sales Share by Application (2021-2032) Figure 55. Asia Lesinurad Revenue Share by Country (2021-2032) Figure 56. Asia Lesinurad Sales Share by Country (2021-2032) Figure 57. SAMEA Lesinurad Revenue Share by Type (2021-2032) Figure 58. SAMEA Lesinurad Sales Share by Type (2021-2032) Figure 59. SAMEA Lesinurad Revenue Share by Application (2021-2032) Figure 60. SAMEA Lesinurad Sales Share by Application (2021-2032) Figure 61. SAMEA Lesinurad Revenue Share by Country (2021-2032) Figure 62. SAMEA Lesinurad Sales Share by Country (2021-2032) Figure 63. Lesinurad Value Chain Figure 64. Manufacturing Cost Structure Figure 65. Lesinurad Production Mode & Process Figure 66. Direct Comparison with Distribution Share Figure 67. Distributors Profiles Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Purity ≥ 98 %
  • Purity ≥ 99 %
Applications
  • Research Institute
  • Pharmaceutical
  • Others
Companies covered
  • Ausun Pharmaceutical
  • Cayman Chemical
  • CHEMO
  • Clearsynth
  • Manus Aktteva Biopharma LLP
  • MSN Labs
  • Nifty Labs
  • Target Mol
  • UQUIFA
  • Meso Chem
  • Vcare Pharmatech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Lesinurad Market by Type
  3. 1.2.1 Global Lesinurad Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Purity ≥ 98 %
  5. 1.2.3 Purity ≥ 99 %
  6. 1.3 Lesinurad Market by Application
  7. 1.3.1 Global Lesinurad Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Research Institute
  9. 1.3.3 Pharmaceutical
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Lesinurad Market Dynamics
  1. 2.1 Lesinurad Industry Trends
  2. 2.2 Lesinurad Industry Drivers
  3. 2.3 Lesinurad Industry Opportunities and Challenges
  4. 2.4 Lesinurad Industry Restraints
3 Global Lesinurad Production Overview
  1. 3.1 Global Lesinurad Production Capacity (2021-2032)
  2. 3.2 Global Lesinurad Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Lesinurad Production by Region
  4. 3.3.1 Global Lesinurad Production by Region (2021-2026)
  5. 3.3.2 Global Lesinurad Production by Region (2027-2032)
  6. 3.3.3 Global Lesinurad Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global Lesinurad Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Lesinurad Revenue by Region
  3. 4.2.1 Global Lesinurad Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Lesinurad Revenue by Region (2021-2026)
  5. 4.2.3 Global Lesinurad Revenue by Region (2027-2032)
  6. 4.2.4 Global Lesinurad Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Lesinurad Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Lesinurad Sales by Region
  9. 4.4.1 Global Lesinurad Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Lesinurad Sales by Region (2021-2026)
  11. 4.4.3 Global Lesinurad Sales by Region (2027-2032)
  12. 4.4.4 Global Lesinurad Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Lesinurad Revenue by Manufacturers
  2. 5.1.1 Global Lesinurad Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Lesinurad Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Lesinurad Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Lesinurad Sales by Manufacturers
  6. 5.2.1 Global Lesinurad Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Lesinurad Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Lesinurad Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Lesinurad Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Lesinurad Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Lesinurad Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Lesinurad Manufacturers, Product Type & Application
  13. 5.7 Global Lesinurad Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Lesinurad Market CR5 and HHI
  16. 5.8.2 2025 Lesinurad Tier 1, Tier 2, and Tier 3
6 Lesinurad Market by Type
  1. 6.1 Global Lesinurad Revenue by Type
  2. 6.1.1 Global Lesinurad Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Lesinurad Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Lesinurad Sales by Type
  5. 6.2.1 Global Lesinurad Sales by Type (2021-2032) & (t)
  6. 6.2.2 Global Lesinurad Sales Market Share by Type (2021-2032)
  7. 6.3 Global Lesinurad Price by Type
7 Lesinurad Market by Application
  1. 7.1 Global Lesinurad Revenue by Application
  2. 7.1.1 Global Lesinurad Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Lesinurad Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Lesinurad Sales by Application
  5. 7.2.1 Global Lesinurad Sales by Application (2021-2032) & (t)
  6. 7.2.2 Global Lesinurad Sales Market Share by Application (2021-2032)
  7. 7.3 Global Lesinurad Price by Application
8 Company Profiles
  1. 8.1 Ausun Pharmaceutical
  2. 8.1.1 Ausun Pharmaceutical Company Information
  3. 8.1.2 Ausun Pharmaceutical Business Overview
  4. 8.1.3 Ausun Pharmaceutical Lesinurad Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 Ausun Pharmaceutical Lesinurad Product Portfolio
  6. 8.1.5 Ausun Pharmaceutical Recent Developments
  7. 8.2 Cayman Chemical
  8. 8.2.1 Cayman Chemical Company Information
  9. 8.2.2 Cayman Chemical Business Overview
  10. 8.2.3 Cayman Chemical Lesinurad Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 Cayman Chemical Lesinurad Product Portfolio
  12. 8.2.5 Cayman Chemical Recent Developments
  13. 8.3 CHEMO
  14. 8.3.1 CHEMO Company Information
  15. 8.3.2 CHEMO Business Overview
  16. 8.3.3 CHEMO Lesinurad Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 CHEMO Lesinurad Product Portfolio
  18. 8.3.5 CHEMO Recent Developments
  19. 8.4 Clearsynth
  20. 8.4.1 Clearsynth Company Information
  21. 8.4.2 Clearsynth Business Overview
  22. 8.4.3 Clearsynth Lesinurad Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 Clearsynth Lesinurad Product Portfolio
  24. 8.4.5 Clearsynth Recent Developments
  25. 8.5 Manus Aktteva Biopharma LLP
  26. 8.5.1 Manus Aktteva Biopharma LLP Company Information
  27. 8.5.2 Manus Aktteva Biopharma LLP Business Overview
  28. 8.5.3 Manus Aktteva Biopharma LLP Lesinurad Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 8.5.4 Manus Aktteva Biopharma LLP Lesinurad Product Portfolio
  30. 8.5.5 Manus Aktteva Biopharma LLP Recent Developments
  31. 8.6 MSN Labs
  32. 8.6.1 MSN Labs Company Information
  33. 8.6.2 MSN Labs Business Overview
  34. 8.6.3 MSN Labs Lesinurad Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 8.6.4 MSN Labs Lesinurad Product Portfolio
  36. 8.6.5 MSN Labs Recent Developments
  37. 8.7 Nifty Labs
  38. 8.7.1 Nifty Labs Company Information
  39. 8.7.2 Nifty Labs Business Overview
  40. 8.7.3 Nifty Labs Lesinurad Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 8.7.4 Nifty Labs Lesinurad Product Portfolio
  42. 8.7.5 Nifty Labs Recent Developments
  43. 8.8 Target Mol
  44. 8.8.1 Target Mol Company Information
  45. 8.8.2 Target Mol Business Overview
  46. 8.8.3 Target Mol Lesinurad Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 8.8.4 Target Mol Lesinurad Product Portfolio
  48. 8.8.5 Target Mol Recent Developments
  49. 8.9 UQUIFA
  50. 8.9.1 UQUIFA Company Information
  51. 8.9.2 UQUIFA Business Overview
  52. 8.9.3 UQUIFA Lesinurad Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 8.9.4 UQUIFA Lesinurad Product Portfolio
  54. 8.9.5 UQUIFA Recent Developments
  55. 8.10 Meso Chem
  56. 8.10.1 Meso Chem Company Information
  57. 8.10.2 Meso Chem Business Overview
  58. 8.10.3 Meso Chem Lesinurad Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 8.10.4 Meso Chem Lesinurad Product Portfolio
  60. 8.10.5 Meso Chem Recent Developments
  61. 8.11 Vcare Pharmatech
  62. 8.11.1 Vcare Pharmatech Company Information
  63. 8.11.2 Vcare Pharmatech Business Overview
  64. 8.11.3 Vcare Pharmatech Lesinurad Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 8.11.4 Vcare Pharmatech Lesinurad Product Portfolio
  66. 8.11.5 Vcare Pharmatech Recent Developments
9 North America
  1. 9.1 North America Lesinurad Market Size by Type
  2. 9.1.1 North America Lesinurad Revenue by Type (2021-2032)
  3. 9.1.2 North America Lesinurad Sales by Type (2021-2032)
  4. 9.1.3 North America Lesinurad Price by Type (2021-2032)
  5. 9.2 North America Lesinurad Market Size by Application
  6. 9.2.1 North America Lesinurad Revenue by Application (2021-2032)
  7. 9.2.2 North America Lesinurad Sales by Application (2021-2032)
  8. 9.2.3 North America Lesinurad Price by Application (2021-2032)
  9. 9.3 North America Lesinurad Market Size by Country
  10. 9.3.1 North America Lesinurad Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Lesinurad Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Lesinurad Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe Lesinurad Market Size by Type
  2. 10.1.1 Europe Lesinurad Revenue by Type (2021-2032)
  3. 10.1.2 Europe Lesinurad Sales by Type (2021-2032)
  4. 10.1.3 Europe Lesinurad Price by Type (2021-2032)
  5. 10.2 Europe Lesinurad Market Size by Application
  6. 10.2.1 Europe Lesinurad Revenue by Application (2021-2032)
  7. 10.2.2 Europe Lesinurad Sales by Application (2021-2032)
  8. 10.2.3 Europe Lesinurad Price by Application (2021-2032)
  9. 10.3 Europe Lesinurad Market Size by Country
  10. 10.3.1 Europe Lesinurad Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Lesinurad Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Lesinurad Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China Lesinurad Market Size by Type
  2. 11.1.1 China Lesinurad Revenue by Type (2021-2032)
  3. 11.1.2 China Lesinurad Sales by Type (2021-2032)
  4. 11.1.3 China Lesinurad Price by Type (2021-2032)
  5. 11.2 China Lesinurad Market Size by Application
  6. 11.2.1 China Lesinurad Revenue by Application (2021-2032)
  7. 11.2.2 China Lesinurad Sales by Application (2021-2032)
  8. 11.2.3 China Lesinurad Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Lesinurad Market Size by Type
  2. 12.1.1 Asia Lesinurad Revenue by Type (2021-2032)
  3. 12.1.2 Asia Lesinurad Sales by Type (2021-2032)
  4. 12.1.3 Asia Lesinurad Price by Type (2021-2032)
  5. 12.2 Asia Lesinurad Market Size by Application
  6. 12.2.1 Asia Lesinurad Revenue by Application (2021-2032)
  7. 12.2.2 Asia Lesinurad Sales by Application (2021-2032)
  8. 12.2.3 Asia Lesinurad Price by Application (2021-2032)
  9. 12.3 Asia Lesinurad Market Size by Country
  10. 12.3.1 Asia Lesinurad Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Lesinurad Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Lesinurad Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Lesinurad Market Size by Type
  2. 13.1.1 SAMEA Lesinurad Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Lesinurad Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Lesinurad Price by Type (2021-2032)
  5. 13.2 SAMEA Lesinurad Market Size by Application
  6. 13.2.1 SAMEA Lesinurad Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Lesinurad Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Lesinurad Price by Application (2021-2032)
  9. 13.3 SAMEA Lesinurad Market Size by Country
  10. 13.3.1 SAMEA Lesinurad Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Lesinurad Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Lesinurad Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Lesinurad Value Chain Analysis
  2. 14.1.1 Lesinurad Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Lesinurad Production Mode & Process
  6. 14.2 Lesinurad Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Lesinurad Distributors
  9. 14.2.3 Lesinurad Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst